- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4166 - 1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
Patent holdings for IPC class A61K 31/4166
Total number of patents in this class: 1232
10-year publication summary
|
78
|
70
|
85
|
97
|
90
|
110
|
97
|
83
|
92
|
53
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20059 |
35 |
| Aragon Pharmaceuticals, Inc. | 71 |
19 |
| Astellas Pharma Inc. | 1083 |
19 |
| Allergan, Inc. | 2337 |
17 |
| F. Hoffmann-La Roche AG | 7941 |
15 |
| Yamo Pharmaceuticals LLC | 21 |
15 |
| Merck Sharp & Dohme LLC | 3760 |
13 |
| Medivation Prostate Therapeutics LLC | 16 |
12 |
| Pfizer Inc. | 3368 |
11 |
| Ovid Therapeutics Inc | 167 |
11 |
| Jazz Pharmaceuticals Research UK Limited | 219 |
11 |
| Shiseido Company, Ltd. | 4104 |
10 |
| Signal Pharmaceuticals, LLC | 181 |
10 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3183 |
10 |
| FLE International S.r.l. | 41 |
10 |
| Dana-Farber Cancer Institute, Inc. | 2585 |
9 |
| Emory University | 1629 |
9 |
| Kangpu Biopharmaceuticals, Ltd. | 36 |
9 |
| Tyme, Inc. | 38 |
9 |
| AstraZeneca AB | 2908 |
8 |
| Other owners | 970 |